EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $92,000 | +3.4% | 2,138 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $89,000 | -11.0% | 2,138 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $100,000 | -24.8% | 2,138 | -31.9% | 0.00% | -50.0% |
Q3 2020 | $133,000 | -11.9% | 3,138 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $151,000 | -78.2% | 3,138 | -79.2% | 0.00% | -77.8% |
Q1 2020 | $694,000 | -23.5% | 15,097 | 0.0% | 0.01% | -10.0% |
Q4 2019 | $907,000 | +6.2% | 15,097 | 0.0% | 0.01% | +11.1% |
Q3 2019 | $854,000 | +1.5% | 15,097 | 0.0% | 0.01% | -10.0% |
Q2 2019 | $841,000 | +10.4% | 15,097 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $762,000 | +25.3% | 15,097 | 0.0% | 0.01% | +11.1% |
Q4 2018 | $608,000 | -41.9% | 15,097 | 0.0% | 0.01% | -40.0% |
Q3 2018 | $1,047,000 | -8.3% | 15,097 | 0.0% | 0.02% | -16.7% |
Q2 2018 | $1,142,000 | +43.6% | 15,097 | 0.0% | 0.02% | +50.0% |
Q1 2018 | $795,000 | -1.4% | 15,097 | 0.0% | 0.01% | +20.0% |
Q4 2017 | $806,000 | -10.4% | 15,097 | 0.0% | 0.01% | -16.7% |
Q3 2017 | $900,000 | -24.4% | 15,097 | 0.0% | 0.01% | -20.0% |
Q2 2017 | $1,191,000 | – | 15,097 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |